MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseaseshas closed a Series A financing round, lead by BVF Partners LP. Other investors included Merck KGaA, Darmstadt, Germany.
Tags :Nicolas Mosimann
The Kellerhals Carrard Startup Desk acted as legal counsel to Qnami, a Quantum Tech startup, in closing its Series A Financing Round raising a total of CHF 4 million. Led by the Venture Capital Funds Runa
Kellerhals Carrard, under the responsibility of partners Claudia Götz Staehelin (pictured), Oliver M. Brupbacher and Nicolas Mosimann, advised Moderna on legal and regulatory aspects related to the establishment of its supply chain for its
The team was led by partner Nicolas Mosimann (Corporate/M&A - pictured) and comprised associates Sophie Holdt, Sarah Schneider (both Corporate/M&A), Samuel Rickli (Notary), Melanie Huber and Larissa Simeon (both Employment).
